Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-11-15Clinical Trial Update: Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating temsirolimus in combination with sorafenib for advanced hepatocellular carcinoma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) [NA]
This document reports the completion of a pilot study evaluating irreversible electroporation (IRE) for treating early-stage hepatocellular …
-
CLINICAL_TRIALS research · 2016-11-08Clinical Trial Update: A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy [Phase 1, Phase 2]
This document updates a Phase 1/Phase 2 clinical trial evaluating CAR-T cell therapy combined with interventional therapy for advanced liver…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer [Phase 2]
A Phase 2 trial evaluating capecitabine (Xeloda) in combination with peginterferon alfa-2a (Pegasys) in treatment-naive participants with ad…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma [Phase 1]
This is a Phase 1 dose-finding and exploratory study evaluating RO5323441 in combination with sorafenib for hepatocellular carcinoma that ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular Carcinoma [Phase 1]
This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of Onartuzumab alone or in combination with Sorafenib in partici…
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection [Phase 3]
Phase 3 trial evaluating adjuvant FOLFOX chemotherapy after surgical resection in hepatocellular carcinoma patients; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer [Phase 2]
Phase 2 trial evaluating cediranib (AZD2171) for locally advanced unresectable or metastatic hepatocellular carcinoma was terminated; result…
-
CLINICAL_TRIALS research · 2016-10-28Clinical Trial Update: Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC [NA]
This document provides an update on a prospective randomized trial comparing laparoscopic versus open liver resection for hepatocellular car…
-
CLINICAL_TRIALS research · 2016-10-25Clinical Trial Update: Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients [NA]
A clinical trial update evaluating the Folfox4 chemotherapy regimen to prevent early postoperative recurrence in patients with hepatocellula…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery
A completed clinical trial investigates factors influencing liver cancer recurrence within 3 years after surgical treatment.
-
CLINICAL_TRIALS research · 2016-10-21Clinical Trial Update: Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients [NA]
A clinical trial update evaluating intraoperative controlled-release 5-fluorouracil therapy to reduce recurrence in hepatocellular carcinoma…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma [Phase 3]
Phase 3 clinical trial evaluating transarterial chemoembolization (TACE) combined with synchronous radiofrequency/microwave ablation for lar…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib
Completed Bayer-sponsored clinical trial investigating therapeutic decisions in hepatocellular carcinoma and the use of sorafenib.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: First Line Hepato Cellular Carcinoma (HCC) [Phase 3]
A Phase 3 trial for first-line hepatocellular carcinoma has completed. The study is sponsored by Bristol-Myers Squibb.
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: Effect of tDCS on Chronic Abdominal Visceral Pain in HCC Patients [NA]
A completed clinical trial evaluated the effect of transcranial direct current stimulation (tDCS) on chronic abdominal visceral pain in pati…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife [Phase 2]
This document reports on a Phase 2 clinical trial evaluating the effectiveness and safety of CyberKnife treatment in patients with hepatocel…
-
CLINICAL_TRIALS research · 2016-10-07Clinical Trial Update: Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a precision cell immunotherapy combined with transcatheter arterial chemoembolization (TACE) for advan…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Hepatocellular Carcinoma (HCC)_Torisel_ [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial of temsirolimus (Torisel) in inoperable hepatocellular carcinoma conducted by the Chinese University of…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma [Phase 1]
Phase 1 trial evaluating Y-90 radiotherapy alone or with Sorafenib in patients with hepatocellular carcinoma awaiting transplant; the study …
-
CLINICAL_TRIALS research · 2016-09-07Clinical Trial Update: A Study of Anlotinib in Patients With Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update for Anlotinib in hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2016-09-02Clinical Trial Update: Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer [Phase 1, Phase 2]
A clinical trial update describes a Phase 1/Phase 2 study of precision cell immunotherapy combined with transarterial chemoembolization (TAC…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating precision cell immunotherapy in combination with transcatheter arterial chemoembolization for advanced l…
-
CLINICAL_TRIALS research · 2016-09-01Clinical Trial Update: A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating combinations of D-CIK immunotherapy with anti-PD-1 therapy in refractory solid tumors, including hepatoce…